If you need more lookups,
subscriptions start at $34 USD/month.
Kara Levine Location
Boston, MA, US
Kara Levine Work
2022 -now Senior Manager, Process Solutions R and D, Cell and Gene Therapy Process Development @
2016 -2022 Head of Systems and Tools, GENM R and D, Cell Therapy Applications @
2014 -2016 Technical Project Manager @
2011 -2014 Senior Scientist - Pharm Chemical Solutions R and D, Cell Culture Development @
2009 -2011 Senior Scientist - Bioprocess R and D, Upstream Processing @
2007 -2009 Biochemical Scientist III - Bioprocess R and D, Chromatography Product Development @
2000 -2007 Post Doctoral Fellow @
Kara Levine Education
University of Massachusetts Medical School
Doctor Of Philosophy (Physiology)
1993-2000
Clark University
Bachelor Of Arts (Biology)
1987-1991
Kara Levine Skills
Pharmaceutical process development
Stem Cells
T cells
Team Leadership
Thought Leadership
Technology Evaluation
Primary Cells
Product Development
Processes Development
Project Planning
New Technology Evaluation
Project Management
Biopharmaceuticals
Cell Culture
Cross-functional Team Leadership
Assay Development
Protein Chemistry
Biochemistry
Biotechnology
Life Sciences
Molecular Biology
Monoclonal Antibodies
Cell Biology
recombinant DNA technology
PCR
Cell
ELISA
Purification
Validation
SQL
Microsoft Office
Sales
Cross Functional Team Leadership
Kara Levine Summary
Kara Levine, based in Boston, MA, US, is currently a Senior Manager, Process Solutions R and D, Cell and Gene Therapy Process Development at MilliporeSigma. Kara Levine brings experience from previous roles at MilliporeSigma, Repligen Corporation and EMD Millipore. Kara Levine holds a 1993 - 2000 Doctor Of Philosophy in Physiology @ University of Massachusetts Medical School. With a robust skill set that includes Pharmaceutical process development, Stem Cells, T cells, Team Leadership, Thought Leadership and more. Kara Levine has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Kara Levine?
Find contact details for 700 million professionals.